193
Views
11
CrossRef citations to date
0
Altmetric
Review

Progress in bipolar disorder drug design toward the development of novel therapeutic targets: a clinician’s perspective

ORCID Icon, , , , , , & show all
Pages 221-228 | Received 22 Aug 2017, Accepted 12 Jan 2018, Published online: 22 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hagar Abuelazm, Omar H. Elsayed & Rif S. El-Mallakh. (2023) Evaluating lumateperone for its use in treating depressive episodes associated with bipolar I or II disorder in adults. Expert Review of Neurotherapeutics 23:8, pages 751-756.
Read now
Mauro Giovanni Carta, Goce Kalcev, Michele Fornaro & Antonio Egidio Nardi. (2021) Novel experimental and early investigational drugs for the treatment of bipolar disorder. Expert Opinion on Investigational Drugs 30:11, pages 1081-1087.
Read now
Mauro Giovanni Carta, Pasquale Paribello, Annalisa Anastasia, Domenico De Berardis, Antonio Egidio Nardi & Michele Fornaro. (2018) Pharmacological management of depression in patients with multiple sclerosis. Expert Opinion on Pharmacotherapy 19:14, pages 1533-1540.
Read now

Articles from other publishers (8)

Ignazia Mocci, Maria Antonietta Casu, Valeria Sogos, Anna Liscia, Rossella Angius, Francesca Cadeddu, Maura Fanti, Patrizia Muroni, Giuseppe Talani, Andrea Diana, Maria Collu & Maria Dolores Setzu. (2023) Effects of memantine on mania‐like phenotypes exhibited by Drosophila Shaker mutants . CNS Neuroscience & Therapeutics 29:7, pages 1750-1761.
Crossref
Yi Zou, Chinthaka Heyn, Anahit Grigorian, Fred Tam, Ana Cristina Andreazza, Simon J. Graham, Bradley J. Maclntosh & Benjamin I. Goldstein. (2023) Measuring Brain Temperature in Youth Bipolar Disorder Using a Novel Magnetic Resonance Imaging Approach: A Proof-of-concept Study. Current Neuropharmacology 21:6, pages 1355-1366.
Crossref
Domenico De Berardis, Michele Fornaro & Claudia Carmassi. (2023) Editorial: Comorbidity in bipolar disorder, volume II. Frontiers in Psychiatry 14.
Crossref
Md. Mominur Rahman, Md. Rezaul Islam, Sadia Afsana Mim, Nasrin Sultana, Dinesh Kumar Chellappan, Kamal Dua, Mohammad Amjad Kamal, Rohit Sharma & Talha Bin Emran. (2022) Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation. Oxidative Medicine and Cellular Longevity 2022, pages 1-22.
Crossref
Ana Catarina Pereira, Joana Oliveira, Sónia Silva, Nuno Madeira, Cláudia M.F. Pereira & Maria T. Cruz. (2021) Inflammation in Bipolar Disorder (BD): Identification of new therapeutic targets. Pharmacological Research 163, pages 105325.
Crossref
Tanaka, Bohár & Vécsei. (2020) Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism. Molecules 25:3, pages 564.
Crossref
Sari Goldstein Ferber, Dvora Namdar, Danielle Hen-Shoval, Gilad Eger, Hinanit Koltai, Gal Shoval, Liat Shbiro & Aron Weller. (2020) The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Current Neuropharmacology 18:2, pages 87-96.
Crossref
Carmine Tomasetti, Chiara Montemitro, Annastasia L.C. Fiengo, Cristina Santone, Laura Orsolini, Alessandro Valchera, Alessandro Carano, Maurizio Pompili, Gianluca Serafini, Giampaolo Perna, Federica Vellante, Giovanni Martinotti, Massimo D. Giannantonio, Yong-Ku Kim, Marco D. Nicola, Antonello Bellomo, Antonio Ventriglio, Michele Fornaro & Domenico D. Berardis. (2019) Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System. Current Pharmaceutical Design 25:4, pages 381-387.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.